Changes in chronic disease medication adherence following oral anticancer agent initiation in patients with multiple myeloma.

被引:0
|
作者
Gatwood, Justin
Dashputre, Ankur
Wallace, Alex
Gatwood, Katie S.
Farris, Karen B.
Mackler, Emily R.
Rizvi-Toner, Amna
Rajpurohit, Abhijeet
Farley, Joel
机构
[1] Univ Tennessee, Coll Pharm, Nashville, TN USA
[2] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
[3] Univ Tennessee, Hlth Sci Ctr, Nashville, TN USA
[4] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[5] Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA
[6] Univ Michigan Hlth Syst, Ann Arbor, MI USA
[7] Univ Minnesota, Coll Pharm, Minneapolis, MN 55455 USA
[8] Univ Minnesota, Coll Pharm, Dept Pharmaceut Care & Hlth Syst, Minneapolis, MN 55455 USA
关键词
D O I
10.1200/JCO.2021.39.15_suppl.e18760
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e18760
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Enhancing patients' understanding of and adherence to oral anticancer medication: Results of a longitudinal pilot intervention
    Lin, Mingqian
    Hackenyos, Douglas
    Savidge, Nicole
    Weidner, Ruth Ann
    Murphy-Banks, Rachel
    Fleckner, Tara
    Parsons, Susan K.
    Rodday, Angie Mae
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (06) : 1409 - 1421
  • [22] Impact of oral oncolytic initiation on medication adherence for pre-existing comorbid chronic conditions
    Dashputre, Ankur A.
    S Gatwood, Katie
    Schmidt, Jillian
    Gatwood, Justin
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (04) : 835 - 845
  • [23] Medication regimen complexity and medication adherence in elderly patients with chronic kidney disease
    Parker, Krystina
    Bull-Engelstad, Ingrid
    Aasebo, Willy
    von der Lippe, Nanna
    Reier-Nilsen, Morten
    Os, Ingrid
    Stavem, Knut
    HEMODIALYSIS INTERNATIONAL, 2019, 23 (03) : 333 - 342
  • [24] Vinorelbine, oral idarubicin and dexamethasone (VRID), as induction therapy in patients with refractory multiple myeloma.
    Glasmacher, A
    Hahn, C
    Fiegl, M
    Ko, Y
    Goldschmidt, H
    Greil, R
    Gieseler, F
    Schmidt-Wolf, I
    BLOOD, 2002, 100 (11) : 385B - 385B
  • [25] Medication Refill Adherence in Patients with Chronic Inflammatory Eye Disease
    Bharadwaj, Arthi D.
    Datta, Avisek
    Bhat, Pooja
    Lobo-Chan, Ann-Marie
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2024,
  • [26] MEDICATION ADHERENCE ASSOCIATED WITH POLYPHARMACY IN CHRONIC KIDNEY DISEASE PATIENTS
    Manju, C. S.
    Anish, B.
    Sreelatha, M.
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2016, 7 (07): : 3107 - 3111
  • [27] Medication Refill Adherence in Patients with Chronic Inflammatory Eye Disease
    Bharadwaj, Arthi
    Song, Amy
    Bhat, Pooja
    Lobo, Ann-Marie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [28] PREVALENCE AND CORRELATES OF MEDICATION ADHERENCE IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Nelson, Jessica
    Yule, Christina
    Berger, Andrea
    Weisbord, Steven
    Green, Jamie
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (04) : A60 - A60
  • [29] Medication adherence evaluation in patients with chronic liver disease.
    Culafic, Milica
    Kovacevic, Sandra Vezmar
    Gosnjic, Nikola
    Filipovic, Marina
    Vucicevic, Katarina
    Miljkovic, Branislava
    Culafic, Djordje
    PHARMACOTHERAPY, 2017, 37 (06): : E45 - E45
  • [30] Incidence of monoclonal B-cell disease in siblings of patients with multiple myeloma.
    Roth, B
    Behringer, D
    Finke, J
    Engelhardt, M
    BLOOD, 2003, 102 (11) : 375B - 375B